Optimal surgical approach to thymic malignancies: New trends challenging old dogmas

E Ruffini, PL Filosso, F Guerrera, P Lausi, P Lyberis… - Lung cancer, 2018 - Elsevier
Until recently, the surgical approach to thymic tumors has remained basically unchanged.
The collaborative effort led by ITMIG with the collaboration of regional and society-based …

Clinical characteristics and outcomes of thymoma‐associated myasthenia gravis

R Álvarez‐Velasco… - European journal of …, 2021 - Wiley Online Library
Background and purpose Prognosis of myasthenia gravis (MG) in patients with thymoma is
not well established. Moreover, it is not clear whether thymoma recurrence or unresectable …

Therapeutic options in thymomas and thymic carcinomas

Y Muto, Y Okuma - Expert Review of Anticancer Therapy, 2022 - Taylor & Francis
Introduction Curative-intent surgery is the best therapeutic option for thymic malignancies.
However, patients with advanced or recurrent thymic malignancies often require palliative …

[HTML][HTML] The International Association for the Study of Lung Cancer Thymic Epithelial Tumor Staging Project: unresolved issues to be addressed for the next ninth …

E Ruffini, R Rami-Porta, J Huang, U Ahmad… - Journal of Thoracic …, 2022 - Elsevier
Thymic epithelial tumors are presently staged using a consistent TNM classification
developed by the International Association for the Study of Lung Cancer (IASLC) and …

Hyperthermic Intrathoracic Chemotherapy (HITHOC) for Pleural disseminated Thymoma: a systematic literature review

T Vandaele, J Van Slambrouck, V Proesmans… - Annals of surgical …, 2023 - Springer
Background Optimal treatment for thymoma with pleural dissemination (TPD) remains
unclear. Extended radical resection is the cornerstone for local treatment but the need for …

[HTML][HTML] Hyperthermic intrathoracic chemotherapy (HITOC) after cytoreductive surgery for pleural malignancies—a retrospective, multicentre study

M Ried, J Kovács, T Markowiak, K Müller, G Huppertz… - Cancers, 2021 - mdpi.com
Simple Summary There continues to be little research in the literature on perioperative
outcomes after cytoreductive surgery (CRS) combined with intraoperative hyperthermic …

Optimal management of thymic malignancies: current perspectives

G Drevet, S Collaud, F Tronc, N Girard… - Cancer Management …, 2019 - Taylor & Francis
Thymic epithelial tumors (TETs) belong to orphan oncology. The incidence of TETs is about
1.3–3.2 cases per million worldwide. Following pathology, evolution and prognosis are …

Surgical treatment of pleural recurrence of thymoma: is hyperthermic intrathoracic chemotherapy worthwhile?

V Aprile, D Bacchin, S Korasidis, A Nesti… - … and thoracic surgery, 2020 - academic.oup.com
OBJECTIVES Recurrence of thymoma is described in 10–30% of cases after surgical
resection. Iterative surgery for thymoma pleural relapses (TPRs) is often part of a multimodal …

[HTML][HTML] Current roles of PET/CT in thymic epithelial tumours: which evidences and which prospects? A pictorial review

F Lococo, M Chiappetta, EKA Triumbari, J Evangelista… - Cancers, 2021 - mdpi.com
Simple Summary Thymic epithelial tumours are uncommon malignancies. Histologically,
they may be distinguished in different subtypes and different relapse risk classes. Surgery …

[HTML][HTML] Outcomes of extended surgical resections for locally advanced thymic malignancies: a narrative review

D Tosi, F Damarco, S Franzi, S Mohamed… - Gland …, 2022 - ncbi.nlm.nih.gov
Methods Diagnostic methods must be chosen accurately to avoid unnecessary surgical
resections, to define the best strategy of care, and to plan the surgical strategy. Therefore …